AMENDMENT TO CONSULTING AGREEMENTConsulting Agreement • March 7th, 2022 • VBI Vaccines Inc/Bc • Pharmaceutical preparations • Ontario
This Amendment to Consulting Agreement (the “Amendment”), effective as of January 1st, 2022 (the “Effective Date”), is by and between Variation Biotechnologies Inc., a corporation incorporated pursuant to the laws of Canada (the “Company”) having an address of 310 Hunt Club Road East, Ottawa, Ontario K1V 1C1 and F. Diaz-Mitoma Professional Corporation (Ontario corporation number 002356634) having an address of 210 Barrow Crescent, Kanata, Ontario K2L 2C7 (“Consultant”). The Consultant and Company are sometimes referred to as a “Party” and are collectively referred to as the “Parties”.
Certain information has been excluded pursuant to Regulation S-K, Item 601(b)(10)(iv) from this Document because it is both not material and is the type that the registrant treats as private or confidential.Agreement • March 7th, 2022 • VBI Vaccines Inc/Bc • Pharmaceutical preparations • England and Wales
THIS AGREEMENT (the “Agreement”) is between Awardee and the Coalition for Epidemic Preparedness Innovations (“CEPI”) and is effective as of the date of the last signature, below (the “Effective Date”). Each party to this Agreement may be referred to individually as a “Party” and together as the “Parties.” This Agreement sets out the terms and conditions governing the performance and funding of the Project (as defined herein). It also reflects the Parties’ mutual commitment to develop a safe and effective vaccine against SARS-CoV-2, to test and obtain regulatory approval for the vaccine as rapidly as possible, consistent with patient safety and achieving vaccine quality, and to ensure the manufacture and distribution of sufficient quantities of the vaccine to meet global demand at affordable prices in the country of use. As a condition of this funding award, the Parties enter into this Agreement by having their authorised representatives sign below.
Certain information has been excluded pursuant to Regulation S-K, Item 601(b)(10)(iv) from this Document because it is both not material and is the type that the registrant treats as private or confidential.VBI Vaccines Inc/Bc • March 7th, 2022 • Pharmaceutical preparations
a Company incorporated under the Canada Business Corporations Act under number 393728-3 whose Registered Office Address is located in:
Certain information has been excluded pursuant to Regulation S-K, Item 601(b)(10)(iv) from this Document because it is both not material and is the type that the registrant treats as private or confidential.VBI Vaccines Inc/Bc • March 7th, 2022 • Pharmaceutical preparations
a departmental corporation forming part of the Government of Canada created by the National Research Council Act (R.S.C. 1985, c. N-15), and an agent of Her Majesty the Queen in Right of Canada whose head office address is:
Certain information has been excluded pursuant to Regulation S-K, Item 601(b)(10)(iv) from this Document because it is both not material and is the type that the registrant treats as private or confidential.VBI Vaccines Inc/Bc • March 7th, 2022 • Pharmaceutical preparations
a Company incorporated under the Canada Business Corporations Act under number 393728-3 whose Registered Office Address is located in:
Certain information has been excluded pursuant to Regulation S-K, Item 601(b)(10)(iv) from this Document because it is both not material and is the type that the registrant treats as private or confidential.VBI Vaccines Inc/Bc • March 7th, 2022 • Pharmaceutical preparations
a Company incorporated under the Canada Business Corporations Act under number 393728-3 whose Registered Office Address is located in:
Amendment 2 to collaboration and license agreementCollaboration and License Agreement • March 7th, 2022 • VBI Vaccines Inc/Bc • Pharmaceutical preparations
This Amendment #2 (hereinafter “Amendment 2”) is signed as of the signature date(s) below and made effective December 20 2021, below (“Amendment 2 Effective Date”) and entered into by and between VBI Vaccines, Inc. a company organized under the laws of the Province of British Columbia, Canada (“VBI”) and having a principal place of business at 310 Hunt Club Road, Suite 201, Ottawa ON K1V 1C1, and Brii Biosciences Limited, an exempted company organized under the laws of the Cayman Islands (“Brii Bio”) having its registered office at Vistra (Cayman) Limited, PO Box 3119, Grand Pavilion Hibiscus Way, 802 West Bay Road Grand Cayman KYI-1205. VBI and Brii Bio are referred to individually as a “Party” and are collectively referred to as the “Parties”.
Certain information has been excluded pursuant to Regulation S-K, Item 601(b)(10)(iv) from this Document because it is both not material and is the type that the registrant treats as private or confidential.VBI Vaccines Inc/Bc • March 7th, 2022 • Pharmaceutical preparations
a Company incorporated under the Canada Business Corporations Act under number 393728-3 whose Registered Office Address is located in:
